Altitude Life Science Ventures is a venture capital firm in Colorado that focuses on life science markets with strong demand and growth potential. Founded 2006 in Durango, Colorado, United States by Steve Johnson and Dave Maki, it invests in early stage ventures and late stage ventures. Its portfolio companies include Omniome, Nuvation Bio, Encoded Therapeutics, Inc., BlackThorn Therapeutics, Vividion Therapeutics, Beam Therapeutics, Millendo Therapeutics, Omniome, UNITY Biotechnology, and Effector Therapeutics. As of March 2020, Altitude Life Science Ventures has made 31 investments. Their most recent investment was on January 9, 2020, when Omniome raised $60M. Altitude Life Science Ventures has had eight exits, the most notable of which include Vir Biotechnology, UNITY Biotechnology, and Receptos. The company has raised a single venture fund, Altitude Life Science Ventures Fund III.
Documentaries, videos and podcasts
Encoded Therapeutics, Inc.